
Chinese biotechnology company founded in 2019 and based in the Zhongxing Shenlan science and technology park in Fengdong New City, Xi'an, Shaanxi, with 25.5 million yuan of registered capital and a team drawn largely from master's and doctoral graduates. Specialises in third-generation single molecule long-read sequencing and its clinical applications, offering research services in animal and plant genomics, transcriptomics and microbiomics alongside clinical testing products, and it built north-west China's first DCS Lab under a strategic partnership with MGI Tech.
Leave your rating